{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:17:42Z","timestamp":1787843862916,"version":"build-2784847793"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01855-x","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:22:17Z","timestamp":1787840537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM32-mediated ubiquitination of STING promotes glycolysis and tumor progression"],"prefix":"10.1038","author":[{"given":"Huaxin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biaofeng","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangshuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-5769","authenticated-orcid":false,"given":"Xiangyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"1855_CR1","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"1855_CR2","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist Update. 2025;78:101170.","journal-title":"Drug Resist Update"},{"key":"1855_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cac2.12204","volume":"41","author":"J Yang","year":"2021","unstructured":"Yang J, Xu R, Wang C, Qiu J, Ren B, You L. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review. Cancer Commun. 2021;41:1257\u201374.","journal-title":"Cancer Commun"},{"key":"1855_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","volume":"33","author":"Y Wang","year":"2023","unstructured":"Wang Y, Patti GJ. The Warburg effect: a signature of mitochondrial overload. Trends Cell Biol. 2023;33:1014\u201320.","journal-title":"Trends Cell Biol"},{"key":"1855_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15:160.","journal-title":"J Hematol Oncol"},{"key":"1855_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","volume":"17","author":"J Lin","year":"2024","unstructured":"Lin J, Rao D, Zhang M, Gao Q. Metabolic reprogramming in the tumor microenvironment of liver cancer. J Hematol Oncol. 2024;17:6.","journal-title":"J Hematol Oncol"},{"key":"1855_CR7","doi-asserted-by":"publisher","first-page":"217156","DOI":"10.1016\/j.canlet.2024.217156","volume":"600","author":"Z Kooshan","year":"2024","unstructured":"Kooshan Z, C\u00e1rdenas-Piedra L, Clements J, Batra J. Glycolysis, the sweet appetite of the tumor microenvironment. Cancer Lett. 2024;600:217156.","journal-title":"Cancer Lett"},{"key":"1855_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR, Patra KC, Jeon SM, Guzman G, et al. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018;9:446.","journal-title":"Nat Commun"},{"key":"1855_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15548627.2023.2247300","volume":"20","author":"Y Feng","year":"2024","unstructured":"Feng Y, Chen Y, Wu X, Chen J, Zhou Q, Liu B, et al. Interplay of energy metabolism and autophagy. Autophagy. 2024;20:4\u201314.","journal-title":"Autophagy"},{"key":"1855_CR10","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int J Biol Sci. 2024;20:3113\u201325.","journal-title":"Int J Biol Sci"},{"key":"1855_CR11","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1016\/j.molcel.2024.09.026","volume":"84","author":"S Nishimura","year":"2024","unstructured":"Nishimura S, Linares JF, L\u2019Hermitte A, Duran A, Cid-Diaz T, Martinez-Ordonez A, et al. Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma. Mol Cell. 2024;84:4660\u2013.e10.","journal-title":"Mol Cell"},{"key":"1855_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jare.2023.09.011","volume":"61","author":"J Tang","year":"2024","unstructured":"Tang J, Li J, Lian J, Huang Y, Zhang Y, Lu Y, et al. CDK2-activated TRIM32 phosphorylation and nuclear translocation promote radioresistance in triple-negative breast cancer. J Adv Res. 2024;61:239\u201351.","journal-title":"J Adv Res"},{"key":"1855_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"Liu F, Chen J, Li K, Li H, Zhu Y, Zhai Y, et al. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol Cancer. 2024;23:148.","journal-title":"Mol Cancer"},{"key":"1855_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","volume":"37","author":"F Mattiroli","year":"2021","unstructured":"Mattiroli F, Penengo L. Histone ubiquitination: an integrative signaling platform in genome stability. Trends Genet. 2021;37:566\u201381.","journal-title":"Trends Genet"},{"key":"1855_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425\u201379.","journal-title":"Annu Rev Biochem"},{"key":"1855_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","volume":"70","author":"CM Pickart","year":"2001","unstructured":"Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem. 2001;70:503\u201333.","journal-title":"Annu Rev Biochem"},{"key":"1855_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases. Annu Rev Biochem. 2009;78:399\u2013434.","journal-title":"Annu Rev Biochem"},{"key":"1855_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","volume":"86","author":"N Zheng","year":"2017","unstructured":"Zheng N, Shabek N. Ubiquitin ligases: structure, function, and regulation. Annu Rev Biochem. 2017;86:129\u201357.","journal-title":"Annu Rev Biochem"},{"key":"1855_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.semcancer.2020.05.002","volume":"67","author":"P Wang","year":"2020","unstructured":"Wang P, Dai X, Jiang W, Li Y, Wei W. RBR E3 ubiquitin ligases in tumorigenesis. Semin Cancer Biol. 2020;67:131\u201344.","journal-title":"Semin Cancer Biol"},{"key":"1855_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.chembiol.2021.04.008","volume":"28","author":"S Duan","year":"2021","unstructured":"Duan S, Pagano M. Ubiquitin ligases in cancer: functions and clinical potentials. Cell Chem Biol. 2021;28:918\u201333.","journal-title":"Cell Chem Biol"},{"key":"1855_CR21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.tibs.2025.07.009","volume":"50","author":"P Ebadi","year":"2025","unstructured":"Ebadi P, Stratton CM, Olsen SK. E3 ubiquitin ligases in signaling, disease, and therapeutics. Trends Biochem Sci. 2025;50:960\u201376.","journal-title":"Trends Biochem Sci"},{"key":"1855_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13046-023-02767-1","volume":"42","author":"S Chen","year":"2023","unstructured":"Chen S, Leng P, Guo J, Zhou H. FBXW7 in breast cancer: mechanism of action and therapeutic potential. J Exp Clin Cancer Res. 2023;42:226.","journal-title":"J Exp Clin Cancer Res"},{"key":"1855_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03608-z","volume":"20","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang MM, Geng Y, Ye CY, Zang YS. Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer. J Transl Med. 2022;20:402.","journal-title":"J Transl Med"},{"key":"1855_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1086\/339083","volume":"70","author":"P Frosk","year":"2002","unstructured":"Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, Morgan K, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002;70:663\u201372.","journal-title":"Am J Hum Genet"},{"key":"1855_CR25","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/hmg\/ddp167","volume":"18","author":"M Locke","year":"2009","unstructured":"Locke M, Tinsley CL, Benson MA, Blake DJ. TRIM32 is an E3 ubiquitin ligase for dysbindin. Hum Mol Genet. 2009;18:2344\u201358.","journal-title":"Hum Mol Genet"},{"key":"1855_CR26","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/febs.17065","volume":"291","author":"S Goyani","year":"2024","unstructured":"Goyani S, Shinde A, Shukla S, Saranga MV, Currim F, Mane M, et al. Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson\u2019s disease. Febs J. 2024;291:2636\u201355.","journal-title":"Febs J"},{"key":"1855_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.7150\/ijbs.106690","volume":"21","author":"X Zhou","year":"2025","unstructured":"Zhou X, Zhao Y, Huang S, Shu H, Zhang Y, Yang H, et al. TRIM32 promotes neuronal ferroptosis by enhancing K63-linked ubiquitination and subsequent p62-selective autophagic degradation of GPX4. Int J Biol Sci. 2025;21:1259\u201374.","journal-title":"Int J Biol Sci"},{"key":"1855_CR28","doi-asserted-by":"crossref","unstructured":"Xu J, Liu W, Chen L, Zhang J, Zhang D, Huang X, et al. TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion. Cell Death Differ. 2026;33:126\u201339.","DOI":"10.1038\/s41418-025-01559-8"},{"key":"1855_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41388-022-02204-1","volume":"41","author":"Y Ma","year":"2022","unstructured":"Ma Y, Zhang H, Chen C, Liu L, Ding T, Wang Y, et al. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer. Oncogene. 2022;41:1589\u201399.","journal-title":"Oncogene"},{"key":"1855_CR30","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1038\/cdd.2014.121","volume":"21","author":"J Liu","year":"2014","unstructured":"Liu J, Zhang C, Wang XL, Ly P, Belyi V, Xu-Monette ZY, et al. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis. Cell Death Differ. 2014;21:1792\u2013804.","journal-title":"Cell Death Differ"},{"key":"1855_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jmcb\/mjz081","volume":"12","author":"M Zhao","year":"2020","unstructured":"Zhao M, Song K, Hao W, Wang L, Patil G, Li Q, et al. Non-proteolytic ubiquitination of OTULIN regulates the NF-\u03baB signaling pathway. J Mol Cell Biol. 2020;12:163\u201375.","journal-title":"J Mol Cell Biol"},{"key":"1855_CR32","doi-asserted-by":"crossref","unstructured":"Chu M, Shi X, Shi Z, Liang Y. PLAAT2 suppresses gastric cancer progression by facilitating cMyc ubiquitination and inhibiting MEK\/ERK signaling. Cell Death Dis. 2026;17:314.","DOI":"10.1038\/s41419-026-08546-y"},{"key":"1855_CR33","doi-asserted-by":"publisher","first-page":"106995","DOI":"10.1016\/j.phrs.2023.106995","volume":"198","author":"L Wang","year":"2023","unstructured":"Wang L, Song YY, Wang Y, Liu XX, Yin YL, Gao S, et al. RHBDF1 deficiency suppresses melanoma glycolysis and enhances the efficacy of immunotherapy by facilitating glucose-6-phosphate isomerase degradation via TRIM32. Pharm Res. 2023;198:106995.","journal-title":"Pharm Res"},{"key":"1855_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, et al. TRIM family contributes to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11:75.","journal-title":"Exp Hematol Oncol"},{"key":"1855_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"KP Hopfner","year":"2020","unstructured":"Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat Rev Mol Cell Biol. 2020;21:501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1855_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.immuni.2024.02.019","volume":"57","author":"S Dvorkin","year":"2024","unstructured":"Dvorkin S, Cambier S, Volkman HE, Stetson DB. New frontiers in the cGAS-STING intracellular DNA-sensing pathway. Immunity. 2024;57:718\u201330.","journal-title":"Immunity"},{"key":"1855_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50999-2","volume":"15","author":"Y Sun","year":"2024","unstructured":"Sun Y, Patterson-Fortin J, Han S, Li Z, Nowicka Z, Hirohashi Y, et al. 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Nat Commun. 2024;15:6676.","journal-title":"Nat Commun"},{"key":"1855_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang C. Regulation of cGAS-STING signalling and its diversity of cellular outcomes. Nat Rev Immunol. 2025;25:425\u201344.","journal-title":"Nat Rev Immunol"},{"key":"1855_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01247-w","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X. cGAS-STING pathway in cancer biotherapy. Mol Cancer. 2020;19:136.","journal-title":"Mol Cancer"},{"key":"1855_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","volume":"43","author":"B Zhang","year":"2025","unstructured":"Zhang B, Xu P, Ablasser A. Regulation of the cGAS-STING pathway. Annu Rev Immunol. 2025;43:667\u201392.","journal-title":"Annu Rev Immunol"},{"key":"1855_CR41","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3:1452\u201363.","journal-title":"Nat Cancer"},{"key":"1855_CR42","doi-asserted-by":"publisher","first-page":"102820","DOI":"10.1016\/j.arr.2025.102820","volume":"111","author":"K Liao","year":"2025","unstructured":"Liao K, Wen J, Liu Z, Zhang B, Zhang X, Fu Y, et al. The role of the intratumoral microbiome in the occurrence, proliferation, and metastasis of colorectal cancer and its underlying therapeutic strategies. Ageing Res Rev. 2025;111:102820.","journal-title":"Ageing Res Rev"},{"key":"1855_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01860-y","volume":"22","author":"J Mahin","year":"2024","unstructured":"Mahin J, Xu X, Li L, Zhang C. cGAS\/STING in skin melanoma: from molecular mechanisms to therapeutics. Cell Commun Signal. 2024;22:553.","journal-title":"Cell Commun Signal"},{"key":"1855_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41423-021-00780-y","volume":"19","author":"WC Chou","year":"2022","unstructured":"Chou WC, Rampanelli E, Li X, Ting JP. Impact of intracellular innate immune receptors on immunometabolism. Cell Mol Immunol. 2022;19:337\u201351.","journal-title":"Cell Mol Immunol"},{"key":"1855_CR45","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","volume":"11","author":"M Jiang","year":"2021","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, et al. Alterations of the DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharmacol Sin B. 2021;11:2983\u201394.","journal-title":"Acta Pharmacol Sin B"},{"key":"1855_CR46","doi-asserted-by":"crossref","unstructured":"Sacrist\u00e1n Santos V, Pensado-L\u00f3pez A, Garc\u00eda-Campelo R, Antol\u00edn Novoa S, Se\u00f1aris Rodr\u00edguez R, And\u00f3n FT. Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers. J Immunother Cancer. 2025;13:e010950.","DOI":"10.1136\/jitc-2024-010950"},{"key":"1855_CR47","doi-asserted-by":"crossref","unstructured":"Wu Y, Lu WM, Cui QR, Zhou J, Lu GD. Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications. Cytokine Growth Factor Rev. 2025;85:43\u201355.","DOI":"10.1016\/j.cytogfr.2025.06.002"},{"key":"1855_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28440-3","volume":"13","author":"CS Blaha","year":"2022","unstructured":"Blaha CS, Ramakrishnan G, Jeon SM, Nogueira V, Rho H, Kang S, et al. A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis. Nat Commun. 2022;13:899.","journal-title":"Nat Commun"},{"key":"1855_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13046-022-02522-y","volume":"41","author":"B Harris","year":"2022","unstructured":"Harris B, Saleem S, Cook N, Searle E. Targeting hypoxia in solid and haematological malignancies. J Exp Clin Cancer Res. 2022;41:318.","journal-title":"J Exp Clin Cancer Res"},{"key":"1855_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s42003-021-02205-y","volume":"4","author":"N Haloi","year":"2021","unstructured":"Haloi N, Wen PC, Cheng Q, Yang M, Natarajan G, Camara AKS, et al. Structural basis of complex formation between mitochondrial anion channel VDAC1 and Hexokinase-II. Commun Biol. 2021;4:667.","journal-title":"Commun Biol"},{"key":"1855_CR51","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1074\/jbc.M109950200","volume":"277","author":"JG Pastorino","year":"2002","unstructured":"Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002;277:7610\u20138.","journal-title":"J Biol Chem"},{"key":"1855_CR52","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 2022;34:1312\u2013.e6.","journal-title":"Cell Metab"},{"key":"1855_CR53","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1158\/0008-5472.CAN-21-1820","volume":"82","author":"J Wang","year":"2022","unstructured":"Wang J, Huang Q, Hu X, Zhang S, Jiang Y, Yao G, et al. Disrupting circadian rhythm via the PER1-HK2 axis reverses trastuzumab resistance in gastric cancer. Cancer Res. 2022;82:1503\u201317.","journal-title":"Cancer Res"},{"key":"1855_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K, et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun. 2021;12:1812.","journal-title":"Nat Commun"},{"key":"1855_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-024-01526-9","volume":"17","author":"M Xue","year":"2024","unstructured":"Xue M, Dong L, Zhang H, Li Y, Qiu K, Zhao Z, et al. METTL16 promotes liver cancer stem cell self-renewal by controlling ribosome biogenesis and mRNA translation. J Hematol Oncol. 2024;17:7.","journal-title":"J Hematol Oncol"},{"key":"1855_CR56","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1002\/hep.31565","volume":"73","author":"T Ooshio","year":"2021","unstructured":"Ooshio T, Yamamoto M, Fujii K, Xin B, Watanabe K, Goto M, et al. Hepatocyte mitogen-activated protein kinase kinase 7 contributes to the restoration of the liver parenchyma following injury in mice. Hepatology. 2021;73:2510\u201326.","journal-title":"Hepatology"},{"key":"1855_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HEP.0000000000000821","volume":"81","author":"W Bu","year":"2025","unstructured":"Bu W, Sun X, Xue X, Geng S, Yang T, Zhang J, et al. Early onset of pathological polyploidization and cellular senescence in hepatocytes lacking RAD51 creates a pro-fibrotic and pro-tumorigenic inflammatory microenvironment. Hepatology. 2025;81:491\u2013508.","journal-title":"Hepatology"},{"key":"1855_CR58","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","volume":"25","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang C, Zhong Y, Sun K, Jing H, Song J, et al. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2. Nat Cell Biol. 2023;25:1208\u201322.","journal-title":"Nat Cell Biol"},{"key":"1855_CR59","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","volume":"14","author":"M Liao","year":"2024","unstructured":"Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang J, et al. Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer. Acta Pharmacol Sin B. 2024;14:953\u20131008.","journal-title":"Acta Pharmacol Sin B"},{"key":"1855_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"1855_CR61","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.123.065880","volume":"149","author":"X Chen","year":"2024","unstructured":"Chen X, Wu H, Liu Y, Liu L, Houser SR, Wang WE. Metabolic reprogramming: A by-product or a driver of cardiomyocyte proliferation? Circulation. 2024;149:1598\u2013610.","journal-title":"Circulation"},{"key":"1855_CR62","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36:1439\u201355.","journal-title":"Cell Metab"},{"key":"1855_CR63","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.kint.2023.09.019","volume":"104","author":"K Kanasaki","year":"2023","unstructured":"Kanasaki K. The aberrant glycolysis in the kidney proximal tubule: potential therapeutic target for DKD. Kidney Int. 2023;104:1056\u20139.","journal-title":"Kidney Int"},{"key":"1855_CR64","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41418-020-00696-6","volume":"28","author":"LM Humphreys","year":"2021","unstructured":"Humphreys LM, Smith P, Chen Z, Fouad S, D\u2019Angiolella V. The role of E3 ubiquitin ligases in the development and progression of glioblastoma. Cell Death Differ. 2021;28:522\u201337.","journal-title":"Cell Death Differ"},{"key":"1855_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01548-2","volume":"21","author":"J Fan","year":"2022","unstructured":"Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, et al. Clinical significance of FBXW7 loss of function in human cancers. Mol Cancer. 2022;21:87.","journal-title":"Mol Cancer"},{"key":"1855_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02069-3","volume":"23","author":"Q Xu","year":"2025","unstructured":"Xu Q, Hua X, Li B, Jiang B, Jin J, Wu R, et al. Intrinsic STING of CD8\u2009+\u2009T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects. Cell Commun Signal. 2025;23:99.","journal-title":"Cell Commun Signal"},{"key":"1855_CR67","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.21037\/jgo-22-957","volume":"13","author":"H Yao","year":"2022","unstructured":"Yao H, Wang S, Zhou X, Sun J, Zhou G, Zhou D, et al. STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway. J Gastrointest Oncol. 2022;13:2458\u201371.","journal-title":"J Gastrointest Oncol"},{"key":"1855_CR68","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cdd.2014.173","volume":"22","author":"DJ Roberts","year":"2015","unstructured":"Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: acting on mitochondria and TORCing to autophagy. Cell Death Differ. 2015;22:248\u201357.","journal-title":"Cell Death Differ"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01855-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:22:18Z","timestamp":1787840538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01855-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":68,"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01855-x","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study involving human participants was conducted in accordance with the principles of the Declaration of Helsinki. The research involving human samples and data was approved by the Scientific Research Ethics Committee of the Second Qilu Hospital of Shandong University (License No. KYLL2023413). Written informed consent was obtained from all participants prior to enrollment in the study. The research did not involve any individuals younger than 18 years. Furthermore, for participants whose identifiable images appear in this manuscript, additional written consent specifically for publication was obtained. All animal experiments were approved by the Animal Use and Care Committee of the Second Qilu Hospital of Shandong University (License No. KYLL2024856). All methods involving live vertebrate animals were performed in accordance with the relevant guidelines and regulations, including the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}